Q3 2026 Earnings Highlights from Key Companies

Business & Economy
The brief

In the third quarter of 2026, Targa Resources reported significant developments, including a 20-year agreement with ExxonMobil and plans for new infrastructure in the Permian Basin. This partnership is expected to enhance Targa's operational capacity and market position in the energy sector.

TC Energy also made headlines with its earnings call, revealing that power demand now constitutes over two-thirds of its $40 billion project pipeline. This shift underscores the growing importance of renewable energy and infrastructure projects that cater to evolving energy needs.S2

ANI Pharma experienced a notable revenue increase of 28% in the same quarter, driven by strategic plans to acquire Egetis for $560 million. This acquisition is poised to strengthen ANI's product offerings and market reach, reflecting a proactive approach to growth in the pharmaceutical industry.S3

In the biopharmaceutical sector, Novavax benefited from a $125 million milestone payment from Sanofi, which significantly boosted its quarterly results. This financial support highlights the collaborative efforts within the industry to advance vaccine development and commercialization.S4

Douglas Emmett reported its largest quarterly occupancy gain since 2012, although the company continues to grapple with rising debt costs that are impacting its overall financial performance. This mixed outcome reflects the ongoing challenges in the real estate market amid fluctuating economic conditions.S5

3D Systems noted that demand from defense and printer sectors helped offset weaknesses in consumer-facing markets during the quarter. This resilience illustrates the company's adaptability in a competitive landscape, focusing on sectors with robust growth potential.S6

Timeline · newest first
2h Fool

Targa Resources (TRGP) Q3 2026 Earnings Call Transcript

Management highlights a 20-year ExxonMobil pact and new Permian infrastructure plans.

2h Fool

TC Energy (TRP) Q3 2026 Earnings Call Transcript

Power demand now drives over two-thirds of its $40 billion project pipeline.

2h Fool

ANI Pharma (ANIP) Q3 2026 Earnings Call Transcript

Revenue rose 28% as ANI plans a $560 million Egetis acquisition.

2h Fool

Novavax (NVAX) Q3 2026 Earnings Call Transcript

Sanofi's $125 million milestone lifted the quarter's results.

2h Fool

Douglas Emmett (DEI) Q3 2026 Earnings Call Transcript

Occupancy posted its largest quarterly gain since 2012, but rising debt costs still weigh on results.

2h Fool

3D Systems (DDD) Q3 2026 Earnings Call Transcript

Defense and printer demand offset weakness in consumer-facing markets this quarter.

2h Fool

Ionic Digital (IOND) Q3 2026 Earnings Call Transcript

Existing leases are ramping cash rent toward a $250 million annualized run rate.

2h Fool

Velocity Financial (VEL) Q3 2026 Earnings Call Transcript

Record originations, and a Toorak deal reshaping the loan mix.

2h Fool

Sturm, Ruger & Company (RGR) Q3 2026 Earnings Call Transcript

Management trimmed low-profit lines and tightened factory operations.

2h Fool

Mativ (MATV) Q3 2026 Earnings Call Transcript

Tornado losses and tariffs weighed, but space films surged.

2h Fool

Orion S.A. (OEC) Q3 2026 Earnings Call Transcript

Orion cut leverage to 4.1x and narrowed guidance despite weaker rubber pricing.

2h Fool

Seaport Entertainment (SEG) Q3 2026 Earnings Call Transcript

Positive operating EBITDA returned for a second straight quarter despite weather.

2h Seekingalpha

Genie Energy Ltd. (GNE) Q3 2026 Earnings Call Prepared Remarks Transcript

"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage": "@type":"WebPage","@id":"https://seekingalpha.com/article/4963413-genie-energy-ltd-gne-q3-2026-earnings-ca…

2h Seekingalpha

Aumovio SE (AMVOY) Q3 2026 Earnings Call Transcript

"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage": "@type":"WebPage","@id":"https://seekingalpha.com/article/4963418-aumovio-se-amvoy-q3-2026-earnings-call-t…

2h Fool

IMAX (IMAX) Q3 2026 Earnings Call Transcript

A nearly doubled box office record fueled an unusually strong quarter.

2h Fool

Vericel Corp (VCEL) Q3 2026 Earnings Call Transcript

Record burn care sales and raised guidance drive momentum.

2h Fool

BlackSky (BKSY) Q3 2026 Earnings Call Transcript

Record revenue and a second guidance raise, plus a new retail investor pilot.

2h Fool

Certara (CERT) Q3 2026 Earnings Call Transcript

Software momentum and cloud migration progress lifted margins despite a services slowdown.

2h Fool

Insight Enterprises (NSIT) Q3 2026 Earnings Call Transcript

Management flagged a slower fourth quarter amid memory pricing concerns.

2h Fool

Radian (RDN) Q3 2026 Earnings Call Transcript

Specialty now drives 34% of adjusted pretax operating income as the mix broadens.

2h Fool

LeMaitre Vascular (LMAT) Q3 2026 Earnings Call Transcript

Management details the B. Braun integration timeline and possible supply gaps.

2h Fool

Dave Inc. (DAVE) Q3 2026 Earnings Call Transcript

Guidance rose, but credit losses came in above forecast.

2h Fool

MNTN (MNTN) Q3 2026 Earnings Call Transcript

Sales turnover and a reset outlook marked the quarter, with a rebuild underway.

2h Fool

Veracyte (VCYT) Q3 2026 Earnings Call Transcript

Decipher volume fell short as Veracyte closed a $150M deal.

2h Fool

Pan American Silver (PAAS) Q3 2026 Earnings Call Transcript

Gold guidance was cut as shareholder returns hit $300 million.

2h Fool

UWM Holdings (UWMC) Q3 2026 Earnings Call Transcript

Management ties its 2027 expense target to AI gains and servicing rights sales.

2h Fool

Gold Royalty (GROY) Q3 2026 Earnings Call Transcript

Record quarterly revenue and a free cash flow turn drove results.

2h Fool

Axcelis (ACLS) Q3 2026 Earnings Call Transcript

Bookings hit their highest level since late 2023 as chip equipment demand rebounds.

2h Fool

REGENXBIO (RGNX) Q3 2026 Earnings Call Transcript

Royalty declines and a litigation gain shaped the quarter's results.

2h Fool

Chimera Investment (CIM) Q3 2026 Earnings Call Transcript

Book value fell 16.5% on rate volatility, but origination volume rose sharply.

2h Fool

Onity Group (ONIT) Q3 2026 Earnings Call Transcript

Servicing income offset originations weakness as profits returned.

2h Fool

Shake Shack (SHAK) Q3 2026 Earnings Call Transcript

Management pointed to culinary innovation and digital growth behind the quarter.

2h Fool

Steve Madden (SHOO) Q3 2026 Earnings Call Transcript

Dolce Vita's footwear run offset a slower Kurt Geiger, lifting the raised full-year outlook.

2h Fool

Palvella (PVLA) Q3 2026 Earnings Call Transcript

QTORIN rapamycin wins priority FDA review for a rare vascular disease.

2h Fool

Himax (HIMX) Q3 2026 Earnings Call Transcript

Automotive driver chip orders are correcting sharply, reshaping the outlook.

2h Fool

N-able (NABL) Q3 2026 Earnings Call Transcript

Renewals have not rebounded, even as high-value customer growth continued.

2h Fool

Cogent (CCOI) Q3 2026 Earnings Call Transcript

Cogent suspends dividend to prioritize refinancing $700 million in 2027 notes.

2h Fool

Brilliant Earth (BRLT) Q3 2026 Earnings Call Transcript

Fine jewelry momentum offset tighter engagement ring budgets this quarter.

Q3 2026 Earnings Highlights from Key Companies

2 outlets 47 reports
The brief

In the third quarter of 2026, Targa Resources reported significant developments, including a 20-year agreement with ExxonMobil and plans for new infrastructure in the Permian Basin. This partnership is expected to enhance Targa's operational capacity and market position in the energy sector.

TC Energy also made headlines with its earnings call, revealing that power demand now constitutes over two-thirds of its $40 billion project pipeline. This shift underscores the growing importance of renewable energy and infrastructure projects that cater to evolving energy needs.S2

ANI Pharma experienced a notable revenue increase of 28% in the same quarter, driven by strategic plans to acquire Egetis for $560 million. This acquisition is poised to strengthen ANI's product offerings and market reach, reflecting a proactive approach to growth in the pharmaceutical industry.S3

In the biopharmaceutical sector, Novavax benefited from a $125 million milestone payment from Sanofi, which significantly boosted its quarterly results. This financial support highlights the collaborative efforts within the industry to advance vaccine development and commercialization.S4

Douglas Emmett reported its largest quarterly occupancy gain since 2012, although the company continues to grapple with rising debt costs that are impacting its overall financial performance. This mixed outcome reflects the ongoing challenges in the real estate market amid fluctuating economic conditions.S5

3D Systems noted that demand from defense and printer sectors helped offset weaknesses in consumer-facing markets during the quarter. This resilience illustrates the company's adaptability in a competitive landscape, focusing on sectors with robust growth potential.S6

Timeline · newest first

Sources · 10 citations

S1S2S3S4S5S6S7S8S9S10 FoolLead 36 reports · EN
Seekingalpha 11 reports · EN